What is Allergy?
Operating out of Lexington and Danville, Kentucky, Allergy, Asthma & Sinus Center functions as a premier clinical provider for patients suffering from complex immunological and respiratory conditions. Under the clinical leadership of Dr. Arun Kadambi, a double board-certified specialist with two decades of practice, the organization provides a comprehensive suite of diagnostic and therapeutic interventions. Their service model, which emphasizes accessibility through same-day appointments, covers a broad spectrum of care including environmental allergy mitigation, food allergy management, and chronic asthma stabilization. The center distinguishes itself by integrating advanced testing protocols with patient-centric treatment plans, effectively positioning itself as a critical healthcare asset in the regional market.
How much funding has Allergy raised?
Allergy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Allergy
PPP
Public-Private Partnership
What's next for Allergy?
With the recent influx of capital, the organization is well-positioned to scale its clinical infrastructure and potentially expand its reach within the Commonwealth of Kentucky. The strategic deployment of these funds will likely focus on optimizing patient throughput, upgrading diagnostic technology, and potentially broadening the scope of its immunotherapy programs. As the center navigates this growth phase, the focus remains on maintaining high-quality clinical outcomes while scaling operations to meet the rising demand for specialized allergy and sinus care. This financial milestone serves as a catalyst for long-term sustainability and operational excellence in a competitive medical services sector.
See full Allergy company page
